|
|
||||||||
Published online before print January 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Institutos de Histología/Patología and
Fisiología, Universidad Austral de Chile, Valdivia;
Departamento de Biología Celular, Facultad de Ciencias Biológicas, Universidad de Concepcion, Chile;
Departamento de Ciencias Fisiológicas and
¶ Centro de Investigaciones Médicas, P. Universidad Católica, Santiago, Chile; and
|| Asthma and Allergy Research Institute, School of Medicine and Pharmacology, University of Western Australia, Perth
1Correspondence: Instituto de Histología y Patología, Universidad Austral de Chile, Casilla 567, Valdivia, Chile. E-mail: cfiguero{at}uach.cl
Human neutrophils play a pivotal role in acute inflammation. However, their capacity to generate bioactive kinin peptides has not been established as yet. We have examined the ability of neutrophil enzymes to release biologically active kinins in vitro from purified human H- and L-kininogens. Neutrophils isolated from human blood were stimulated with f-Met-Leu-Phe, thrombin, or human immunoglobulin G adsorbed to silica particles. Supernatants were incubated with iodinated kininogens, and polyacrylamide gel electrophoresis analyzed aliquots taken after a range of incubation times. A time-course analysis demonstrated that supernatants from stimulated neutrophils caused a rapid hydrolysis of both substrates, resulting in an accumulation of fragments ranging from 20 to less than 10 kDa. Radioimmunoassay (RIA) revealed that all supernatants were able to generate kinins in vitro. High-performance liquid chromatography of the generated peptides indicated that they had a retention time similar to that of bradykinin and Met-Lys-bradykinin, clearly recognized as kinin peptides when the corresponding fractions were tested by RIA. The kinin-immunoreactive fractions produced lowering of blood pressure and a dramatic increase in venular permeability. Biological activity of the neutrophil-generated kinins was completely abolished by the B2 receptor antagonist HOE140, indicating that over the time-course of the experiments, only kinin B2 agonists appeared to have been generated and that cellular actions of these were mediated by kinin B2 receptors. Together, our results demonstrate that human neutrophil proteases can release kinins from both plasma kininogens, suggesting that these peptides may participate actively during acute inflammation.
Key Words: neutrophil kallikrein degranulation kinin B2 receptor inflammation
This article has been cited by other articles:
![]() |
T. M. Cunha, W. A. Verri Jr., I. R. Schivo, M. H. Napimoga, C. A. Parada, S. Poole, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha Crucial role of neutrophils in the development of mechanical inflammatory hypernociception J. Leukoc. Biol., April 1, 2008; 83(4): 824 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ehrenfeld, C. Millan, C. E. Matus, J. E. Figueroa, R. A. Burgos, F. Nualart, K. D. Bhoola, and C. D. Figueroa Activation of kinin B1 receptors induces chemotaxis of human neutrophils J. Leukoc. Biol., July 1, 2006; 80(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Dlamini and K D Bhoola Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma J. Clin. Pathol., September 1, 2005; 58(9): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |